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ttempts to repair muscle damage in Duchenne
muscular dystrophy (DMD) by transplanting skeletal
myoblasts directly into muscles are faced with the
problem of the limited migration of these cells in the muscles.
The delivery of myogenic stem cells to the sites of muscle
lesions via the systemic circulation is a potential alternative
approach to treat this disease. Muscle-derived stem cells
(MDSCs) were obtained by a MACS
 
®
 
 multisort method.
 
Clones of MDSCs, which were Sca-1
 

 
/CD34
 

 
/L-selectin
 

 
,
were found to adhere firmly to the endothelium of 
 
mdx
 
dystrophic muscles after i.v. or i.m. injections. The subpop-
ulation of Sca-1
 

 
/CD34
 

 
 MDSCs expressing L-selectin was
A
 
called homing MDSCs (HMDSCs). Treatment of HMDSCs
with antibodies against L-selectin prevented adhesion to
the muscle endothelium. Importantly, we found that vascular
 
endothelium from striate muscle of young 
 
mdx
 
 mice ex-
presses mucosal addressin cell adhesion molecule-1 (MAd-
CAM-1), a ligand for L-selectin. Our results showed for the
first time that the expression of the adhesion molecule
L-selectin is important for muscle homing of MDSCs. This
discovery will aid in the improvement of a potential ther-
apy for muscular dystrophy based on the systemic delivery
of MDSCs.
 
Introduction
 
The absence of dystrophin in the membrane-associated cyto-
skeleton of muscle fibers leads to their degeneration, resulting
in a lethal muscle wasting disease known as Duchenne mus-
cular dystrophy (DMD) (Hoffman et al., 1987; Emery,
1989). The number of satellite cells (myogenic precursors)
in dystrophic muscles decreases over repeated cycles of
degeneration and regeneration, and eventually there are not
enough cells to allow adequate muscle regeneration. The
skeletal muscle is then replaced by connective tissue, leading
to a progressive muscle weakness.
Populations of pluripotent stem cells were obtained from
muscles using different procedures. A side population (SP)
was initially obtained from muscles by FACS
 
®
 
 on the basis
of Hoechst dye exclusion (Gussoni et al., 1999; Jackson et
al., 1999). Muscle-derived stem cells (MDSCs) were also
obtained by a series of preplatings and shown to express
Sca-1 and CD34 (Lee et al., 2000; Deasy et al., 2001; Torrente
et al., 2001). These MDSCs have the capacity to differentiate
into all major blood lineages in vitro (Torrente et al., 2001).
Moreover, bone marrow restoration was observed after
injection of muscle SP cells (a stem cell population obtained
by FACS
 
®
 
) into the tail vein of lethally irradiated mice
(Jackson et al., 1999). Of particular significance is the obser-
vation that transplanted SP cells isolated from bone marrow
or muscle also actively participated in myogenic regeneration.
MDSCs and satellite cells are distinct cell populations, as
demonstrated by the normal numbers of MDSCs and the
complete absence of satellite cells in Pax7 (gene specifically
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expressed in myoblasts derived from satellite cells) mutant
muscles (Seale et al., 2000).
However, the relationship between MDSCs and the mech-
anisms underlying the muscle regeneration are still poorly un-
derstood: do they remain as a quiescent pool or do they con-
tribute to form skeletal muscle fibers after extensive tissue
degeneration? Systemic transplantation of bone marrow–
derived stem cells or even of MDSCs had a very limited im-
pact on muscle cell replacement and did not improve murine
muscular dystrophy (Ferrari et al., 2001; Torrente et al., 2001).
This might be explained by poor recruitment of bone marrow–
derived stem cells and MDSCs to the dystrophic muscle. An
understanding of the nature of the factors responsible for stem
cell homing to muscles will be invaluable in attempts to im-
prove systemic delivery of stem cells for muscle diseases.
In this context, our attention was focused on the expres-
sion of adhesion molecules involved in muscle homing by
MDSCs. MACS
 
®
 
 multisort columns were used to enrich
Sca-1
 

 
/CD34
 

 
 MDSCs. We identified a clonable subset of
MDSCs expressing L-selectin, an adhesion molecule critical
for transendothelial migration of the blood- and bone mar-
row–derived cells. This subset of MDSCs will be referred to as
homing MDSCs (HMDSCs). Using intravital microscopy,
we showed that these HMDSCs adhered firmly to the endo-
thelium of 
 
mdx
 
 muscle microvessels after i.v. or i.m. injec-
tions. Treatment of HMDSCs with an antibody against
L-selectin prevented their adhesion to the blood vessels. Intra-
venous injections of HMDSCs, obtained from transgenic new-
born mice carrying a LacZ reporter gene under the desmin
promoter, produced 
 

 
-galactosidase (
 

 
-gal)– and dystrophin-
positive fibers in many muscles. The discovery of the mecha-
nism involved in the muscle homing of MDSCs will aid in
the improvement of a potential therapy for muscular dystro-
phy based on the systemic delivery of such stem cells.
 
Results
 
Ability of injected MDSCs to induce chimera 
in 
 
mdx
 
 mice
 
To isolate the MDSCs, we used a previously described ap-
proach that had proven successful for the isolation of stem
and progenitor cells from the muscle, namely preplatings
(Qu et al., 1998; Torrente et al., 2001). 500,000 MDSCs
from male F1 Balb/c-C57BL10J mice (H2db) were injected
intramuscularly in 10 female 
 
mdx
 
/
 
mdx
 
 mice (H2b). Using
donor cells from an F1 donor, thus expressing the host and
the donor major histocompatibility complexes (H2db), pre-
vented a graft versus host disease. The presence of donor-
derived cells in blood and bone marrow was still detectable
by FACS
 
®
 
 analysis for H2d. The donor cells were also evi-
dent by PCR for the Y chromosome in the injected tibialis
anterior (TA) muscle, controlateral hind limb muscles, blood,
and bone marrow, but not in sample organs such as the
liver, spleen, lung, and brain (Fig. 1 b). The animals seemed
in good health throughout the experimental period (3 wk).
At 1 and 3 wk after i.m. injection of MDSCs, the flow cyto-
metric analysis of peripheral blood nucleated cells revealed
the presence of 
 

 
1% positive H2d (donor) cells. A similar
percentage (0.1–0.5%) was also detected in the bone mar-
row tissues after 3 wk. Recipient blood and bone marrow tis-
sues were analyzed for the presence of donor MDSCs by
double staining for H2d and one of the following markers:
Sca-1, Flk-1, CD34, CD90, and CD45. 3 wk after MDSC
i.m. engraftment, whole-body perfusion with saline solution
was done to exclude contamination of circulating cells in tis-
sues. Muscle tissues were dissociated mechanically and enzy-
matically and analyzed by FACS
 
®
 
 for H2d donor antigen.
We observed 
 

 
5% of donor cells in the controlateral hind
limb muscle tissues, and the cells expressing H2d also ex-
pressed the stem cell markers Sca-1 and CD34 (Fig. 1 c).
This analysis indicated a selective engraftment by donor cells
of mesodermal origin.
To determine whether donor MDSCs present in the bone
marrow tissues of 
 
mdx
 
 are differentiated and able to induce
tolerance, we grafted the skin of F1 Balb/c-C57BL/10J male
(H2db) into 6 of the 10 female 
 
mdx
 
/
 
mdx
 
 mice (H2b) 2 wk
after the i.m injection of MDSCs. All the recipient 
 
mdx
 
/
 
mdx
 
mice rejected the skin grafts within 7 d. FACS
 
®
 
 analysis
showed that chimeric donor H2db cells extracted from the
host muscles, blood, and bone marrow were CD45 negative.
These data indicate that MDSCs in the chimeric bone mar-
row of 
 
mdx
 
/
 
mdx
 
 mice maintained a stem cell state (Sca-1
 

 
,
CD34
 

 
, and lineage negative) and did not express hemato-
poietic activity.
 
Adhesion of one subpopulation of MDSCs 
to muscle microcirculation
 
MDSCs (obtained by a series of six preplatings) contain cells
capable of adhesion to muscle blood vessels, migration, en-
graftment, and myogenic differentiation after intravascular
injection in mice (Torrente et al., 2001). Flow cytometric
analysis for Sca-1 and CD34 of MDSCs showed different
subpopulations. One subpopulation comprising 69% of the
MDSCs was positive for both Sca-1 and CD34. A second
subpopulation containing 24% of the MDSCs was Sca-1
positive but CD34 negative, and a third subpopulation was
only positive for CD34 (7%) (Fig. 1 a).
To identify which cells within the MDSCs were capable
of muscle homing, the MDSCs were separated into subpop-
ulations (i.e., Sca-1
 

 
/CD34
 

 
, Sca-1
 

 
/CD34
 

 
, and Sca-1
 

 
/
CD34
 

 
) by immunomagnetic selection (MACS
 
®
 
 multisort).
We then tested the adhesion to muscle blood vessels of these
three subpopulations of MDSCs. Boluses of 5 
 

 
 10
 
5
 
 fluo-
rescently labeled cells were injected into the tail vein or into
the quadriceps muscle, and their adhesion to the pectoral
muscle vessels was recorded. After i.v. or i.m. injections, no
vascular interaction was observed for the Sca-1
 

 
CD34
 

 
 sub-
population. A few Sca-1
 

 
/CD34
 

 
 cells interacted with mus-
cle capillaries after i.v. injection but not after i.m. injection.
The Sca-1
 

 
/CD34
 

 
 cells were clearly distinguishable from
the other two MDSC subpopulations by their significant
migration within injected quadriceps after single injection
(Fig. 2, c and d). The 
 

 
-gal staining of muscles injected with
Sca-1
 

 
/CD34
 

 
 MDSCs derived from ROSA26 mice con-
firmed the presence of donor cells spread within myofibers
and near muscle capillaries and arterioles (Fig. 2, e–g).
Moreover, after i.m. injections, these cells were able to mi-
grate from the injected muscle tissue to the blood stream
and then adhered to the endothelial lining of several distant
muscles (Fig. 2, h–m).
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Bone marrow homing and reconstitution after lethal 
irradiation by injection of bone marrow cells 
and Sca1
 

 
/CD34
 

 
 MDSCs
 
To assess the bone marrow homing and hematopoietic activ-
ity of Sca-1
 

 
/CD34
 

 
 MDSCs, we injected them into lethally
irradiated 
 
mdx
 
/
 
mdx
 
 mice. Mice transplanted only with Sca-
1
 

 
/CD34
 

 
 MDSCs in initial experiments did not survive,
perhaps as consequence of the reduced number of injected
cells or because of their reduced expansion capacity. However,
as expected, the transplantation in control mice of bone mar-
row cells (derived from mice of the host strain) alone provided
a sufficient number of hematopoietic stem cells to rescue the
mice from lethal irradiation. This result permitted us in a fol-
low-up experiment to measure the ability of donor Sca-1
 

 
/
CD34
 

 
 MDSCs to home and repopulate the host bone mar-
row tissue when injected in combination with a known quan-
tity of host bone marrow cells, as a competitive population,
as previously done (Jackson et al., 1999). Thus, 50 
 

 
 10
 
5
 
MDSCs were prepared from the muscles of donor Balb/c
mice (H-2d), mixed with 1 
 

 
 10
 
7
 
 bone marrow–derived cells
from host C57BL10J 
 
mdx
 
/
 
mdx
 
 mice (H-2b), and transplanted
into lethally irradiated 
 
mdx
 
/
 
mdx
 
 mice. At 6, 9, and 19 wk after
transplantation, peripheral blood was drawn from the recipi-
ents and analyzed by antibody staining and flow cytometry for
the presence of donor (H-2d) B cells (B220 positive), T cells
(CD90 positive), and granulocytes/macrophages (Gr-1
 

 
/
Mac-1
 

 
). Transplanted animals had 3–15% of their white
blood cells, which were H-2d positive (Table I). After 19 wk,
donor cells were present at high levels in each of the lymphoid
and myeloid lineages, and the proportions of B cells, T cells,
and granulocytes/macrophages derived from donor Sca-1
 

 
/
CD34
 

 
 MDSCs were 2, 13, and 66%, respectively. The over-
all distribution of B, T, and myeloid cells in this mouse was
normal. To confirm the self-renewal capacity of MDSCs, a re-
population of lymphoid and myeloid cell compartments in
secondary recipients was also performed. In this experiment,
the bone marrow from the rescued irradiated 
 
mdx
 
/
 
mdx
 
 mouse
with the highest level of H-2d circulating cells was trans-
planted at 8 
 

 
 10
 
5
 
 mononucleated cells per mouse into each
of five lethally irradiated 
 
mdx
 
/
 
mdx
 
 recipients. After 6 wk, the
peripheral blood was analyzed by flow cytometry. The bone
marrow from this mouse rescued all five secondary recipients
from lethal irradiation and contributed appreciably to the B,
T, and myeloid cell compartments. The mean percentage of
Figure 1. FACscan® immunophenotyping of the muscle-derived cells isolated using MACS® columns. The MDSCs obtained by six preplatings 
were tested for CD34 and Sca-1 antigen expression. Three distinct populations of MDSCs were obtained: Sca-1/CD34 (a, first screen), 
Sca-1/CD34 (a, second screen), and Sca-1/CD34 (a, third screen). In b, the donor cells were detected by PCR for the Y chromosome in 
the hind limb muscles (lane 1), blood (lane 2), and bone marrow (lane 3), but not in samples from organs such as the liver (lane 4), spleen 
(lane 5), lung (lane 6), and brain (lane 7). 3 wk after i.m. transplantation of H2d unselected MDSCs in mdx mice (H2b), engrafted tissues were 
analyzed by FACS® for the presence of positive H2d (donor) cells (c). The positive H2d cells from the blood tissue (boxed region indicated in 
the second quadrant of the blood row) of the injected animals represent 0.1% of the total bloodstream. A similar percentage (1%) of donor 
cells was also detected in the bone marrow tissues after 3 wk (c, bone marrow row). We observed 5% donor cells in the controlateral hind 
limb muscles. The H2d expression in the bloodstream correlates with the expression of Flk-1 and stem cell marker Sca-1, whereas in the bone 
marrow, donor cells coexpressed the CD90 (12%) and Sca-1 (85%) antigens (c). The muscle tissue also contained some donor cells positive 
for Flk-1, CD34, and Sca-1 markers. A few donor cells (H2d positive) were also positive for CD34 (45%), Sca-1 (20%), or Flk1 (3%), as indicated 
by double immunostaining.
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H-2d
 

 
 cells in the peripheral blood of these mice was 2%, and
there were lower percentages of B (1.5%) and T (2%) cells
and granulocytes/macrophages (11%) than in the original re-
cipients (Table I). These data are in accordance with the re-
sults previously demonstrated by Jackson et al. (1999).
 
Identification of adhesion molecules involved 
in muscle homing
 
We then attempted to identify the adhesion molecules
present on the Sca-1/CD34 MDSCs that may be respon-
sible for their attachment to the blood vessels. The presence
of several candidate adhesion molecules was thus investi-
gated by FACS® analysis. No expression of E-selectin,
P-selectin, VLA-4, LFA-1, PFGL-1, or ICAM-1 was ob-
served on MDSCs. However, 30% of the Sca-1/CD34
MDSCs expressed L-selectin. The other two subpopulations
of MDSCs (i.e., Sca-1/CD34 and Sca-1/CD34) did
not express L-selectin.
To verify whether L-selectin was involved in the adhesion
of MDSCs to blood vessels, we treated Sca-1/CD34
MDSCs with antibodies to L-selectin before their i.v. injec-
tion. This treatment reduced 70% of the adhesion of these
cells to the muscle blood vessels. This demonstrated that
L-selectin is involved in the migration of MDSCs to the
muscles. Adhesion fractions of injected MDSCs were deter-
mined by counting the number of interacting cells in each
muscle vessel per number of cells that passed through the same
vessel during an injection. The subpopulation of MDSCs
(Sca-1/CD34/L-selectin) capable of adhesion to muscle
blood vessels represents 3% of all MDSCs and will thus be
Figure 2. We tested the adhesion of 
the Sca-1/CD34/L-selectin positive 
cells (HMDSCs) to muscle blood vessels 
by intravital microscopy. Boluses of 
5  105 fluorescently (BCECF) labeled 
cells were injected into the quadriceps 
muscle, and their adhesion to the pectoral 
muscle vessels was recorded. To improve 
contrast between the intra- and extra-
vascular compartments, the animals 
were injected intravenously with a low 
dose of FITC–dextran. The time course 
study, i.e., before (a), during (b), and 
after (c and d) i.m. injections, indicates 
a significant migration of the HMDSCs 
within the injected muscle. -Gal staining 
of ROSA26-derived HMDSCs showed 
the presence of injected cells along the 
injection site (e), near myofibers, bleeding 
vessels (f), and arterioles (g). Moreover, 
after i.m. injections in quadriceps, the 
HMDSCs were able to migrate to the 
blood stream and then adhered to
the endothelial lining of several distant 
muscles, such as pectoralis (h–m). 
Arrows in i, k, and m indicate migrated 
BCECF-labeled cells (bright dots) in the 
perivascular space of a muscle venule 
1 h after injection.
Table I. Multilineage engraftment in mdx/mdx mice transplanted with HMDSCs
6 wk after injection (7a) 9 wk after injection (13a) 19 wk after injection (9a) Secondary recipients 6 wk after injection (5a)
% % % %
CD90 3 5.8 6 2
CD45 22 32 34 12
CD43 0.1 0.4 1 0
CD11 5.5 7.5 8 3
Gr-1/Mac1 33.6 45.5 66 11
B220 2.3 1.7 3 1.5
CD4 1.9 1.9 3.4 1.8
CD8 2 2.3 3.6 2.1
Sca-1 0.1 0.1 0.1 0.1
CD34 0.2 0.2 0.18 0.1
Blood chimerism of donor-derived (H-2d) cells after transplantation of 50  105 Sca-1/CD34/L-selectin from the muscles of donor Balb/c mice (H-2d)
mixed with 1  107 bone marrow–derived cells from host C57BL10J mdx/mdx mice (H-2b). Repopulation of lymphoid and myeloid cell compartments in
secondary recipients injected with bone marrow of rescued lethally irradiated mdx/mdx mice. Results are expressed as mean percentage.
aNumber of total animals treated.
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referred to as homing MDSCs (HMDSCs). To increase the
percentage of HMDSCs, we cloned the Sca-1/CD34
MDSCs obtained from newborn Des-LacZ mice. Among
the 30 clones produced, two (named G13 and F9) expressed
the L-selectin on all cells and CD44 adhesion markers on
30% of these cells (unpublished data). The morphology of
these cells was similar to medium-sized blast cells. In a myo-
genic differentiation medium, G13 and F9 clones lost the
L-selectin expression (Fig. 3 a), indicating a specific correla-
tion between the loss of this adhesion molecule and the lin-
eage commitment of these stem cells. These clones produced
cells expressing either myosin heavy chain (MyHC) (markers
of late myogenic differentiation) or desmin and m-cadherin
(markers of quiescent muscle satellite cells), indicating two
characteristics of the myogenic potential of the HMDSCs
(Fig. 3, d–g). These data were confirmed by immunoblot
analysis. Multinucleated MyHC-positive myotubes were also
observed after a 14-d culture of Sca-1/CD34/L-selectin
MDSC clones. These results indicate that L-selectin expres-
sion in the Sca-1/CD34 MDSC subpopulation does not
correlate with the capacity to differentiate into muscle cells.
Metalloproteinases are a family of molecules that are critical
in cell migration and remodeling of the ECM. We observed
that HMDSCs expressed higher levels of MMP-2 and
MMP-9 than myoblasts obtained after HMDSC commit-
ment (Fig. 3 h). These data support the notion that the high
migratory capacity of HMDSCs is the result of a combina-
tion of factors.
Quantification and distribution of attachment 
to blood vessels of clonally expanded HMDSCs
To quantify the inhibition of the binding of HMDSC clone
G13 to the muscle blood vessels produced by the L-selectin
antibody, we labeled these cells by growing them for 4 h with
200 Ci/ml [3H]glycerol. This quantification method was
optimized to detect a small number of accumulated cells. The
cells were divided in two pools, one was treated with an anti–
L-selectin antibody at 50 g/ml. Anti–L-selectin was found to
be functional, as assessed by binding/blocking assays with an
L-selectin–transfected cell line (unpublished data). Each pool
of cells (5  105 cells per animal) was injected intravenously
in two groups of mdx/mdx mice. Group 1 was 2 mo old (n 	
5), and group 2 was 1 yr old (n 	 5). The radioactivity was
compared 2 h after HMDSC injection. To demonstrate that
the radioactivity detected in the engrafted tissues was only due
to the HMDSC accumulation and not to nonspecific leaking
of radioactivity, we injected cell lysates from radiolabeled cells
as a control (Table II). We found a low percentage of tissue
incorporation of lysate-derived radioactivity (mostly in the
liver). Moreover, to exclude the potential effects of the com-
plement, five mdx/mdx animals were injected with HMDSCs
pretreated with the F(ab’)2 anti–L-selectin. This treatment re-
vealed similar tissue distribution in comparison to the animals
injected with the HMDSCs treated with anti–L-selectin (Ta-
ble II). After the injection of intact HMDSCs not treated
with anti–L-selectin, the radioactivity was detected prevalently
in muscle tissues such as TA, quadriceps, pectoral, diaphragm,
and triceps brachii muscles but not in lungs, liver, and kidneys
of 2-mo-old mdx/mdx mice. However, a significant decrease
in muscle radioactivity (P  0.001) was observed in 2-mo-old
mdx/mdx mice injected with HMDSCs treated with anti–
L-selectin (Table II). Muscles of 1-yr-old mdx/mdx injected
animals revealed a marked reduction of the radioactivity (P 
0.001) and no difference between animals injected with
HMDSCs and HMDSCs treated with anti–L-selectin (Fig. 5;
Table II). Organs showed no significant differences in distri-
bution between both groups of mdx/mdx mice, as shown in
Table II. Note also that the level of radioactivity was much
lower in organs than in muscles. We also qualitatively assessed
the muscle localization of [3H]glycerol HMDSC clone G13
Figure 3. Myogenic differentiation of Sca-1/CD34 MDSCs in 
cultures. Characterization of Sca-1/CD34 MDSCs from Rosa26 
and Des-LacZ transgenic mice for the L-selectin expression (a). 
L-selectin expression by Sca-1/CD34 MDSCs (a, first screen) was 
decreased when these cells differentiated in myoblasts (a, second 
screen) and lost when they formed myotubes (a, third screen). For 
cloning, single cells within the Sca-1/CD34 MDSCs (b, inset) were 
plated in proliferative conditions described in the Materials and 
methods section. Sca-1/CD34/L-selectin cells (HMDSCs) obtained 
from clone G13 differentiated well into myotubes (b and c) express-
ing the late myogenic marker MyHC (d). Few round single cells near 
myotubes were positive for the expression of m-cadherin (e) and 
desmin (f) markers. Panel g corresponds to the merging of e and f. 
Metalloproteinase activity of the HMDSCs (h, lane 2) was also tested 
and compared with that of myoblasts (h, lane 1). (i) Immunoblotting 
analysis of slow MyHC and m-cadherin by HMDSCs obtained from 
clone G13. The first lane of all immunoblottings corresponds to a 
homogenate of clone G13. 3T3 fibroblast and G8 myoblast cell lines 
were used as controls. Utrophin immunoblotting indicated that the 
same total protein concentrations were present in all specimens.
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by autoradiography. [3H]glycerol-labeled cells were distrib-
uted around the muscle fibers and near the muscle blood ves-
sels. The number of [3H]glycerol-labeled cells per section re-
flected the level of radioactivity detected in the tissue (Fig. 4,
a–d). Donor [3H]glycerol-labeled cells were indeed found in
the pectoral, soleus, gastrocnemius, TA, and triceps brachii of
Figure 4. Localization in the muscle, 
by autoradiography, 2 h after the i.v. 
injection of HMDSC clone G13 labeled 
with [3H]glycerol. The [3H]glycerol-
labeled cells were distributed around the 
muscle fibers and near the muscle vessels 
(a–d). More [3H]glycerol-labeled cells 
were observed per section of the pec-
toralis muscle in the group of mdx mice 
injected with HMDSCs without the anti–
L-selectin treatment (a, 20; c, 40) 
than in the group treated with anti–
L-selectin (b, 20; d, 40). HMDSCs 
participated actively after i.v. injection 
to muscle formation in mdx mice. A 
small number of -gal–positive nuclei 
were observed in myofibers 60 d after 
injection in muscles of HMDSCs ob-
tained from Des-LacZ transgenic mice, 
thus having a nuclear LacZ reporter gene 
(e and g). Fewer labeled nuclei were ob-
served in the muscles of mice pretreated 
with anti–L-selectin (f and h). In these 
experiments, the myofibers containing 
Des-LacZ–positive nuclei coexpressed 
the normal dystrophin protein after immunoperoxidase reaction (e–h, arrows). Some LacZ-positive cells (e, arrowheads) were also found near 
regenerating myofibers. Radioactivity was significantly increased 2 h after the injection of HMDSCs in muscles of mdx mice compared with 
muscles injected with HMDSCs  anti–L-selectin (*, P  0.001) (j). Organ analysis showed no statistically significant differences in radioactivity 
between groups receiving HMDSCs versus HMDSCs  anti–L-selectin at the observed time point (i.e., 2 h) (i). To exclude the potential effects 
of the complement, mdx/mdx animals were also injected with HMDSCs pretreated with F(ab’)2 anti–L-selectin. Lysates from radiolabeled 
cells were injected as a control for nonspecific binding of radioactivity.
Figure 5. Muscle migration of HMDSCs 
in dystrophic muscle is age dependent. 
The radioactivity was significantly 
increased 2 h after the i.v. injection of 
HMDSC clone G13 labeled with 
[3H]glycerol in muscles of 2-mo-old 
mdx/mdx mice receiving HMDSCs versus 
1-yr-old dystrophic animals injected with 
the HMDSCs (P  0.001). The radio-
activity levels in the diaphragm and 
pectoralis muscles of 2-mo-old mdx/mdx 
mice were respectively six- and fivefold 
higher than in muscles injected with 
HMDSCs treated with anti–L-selectin 
(*, P  0.001). Muscle radioactivity levels 
in older (1-yr-old) mdx/mdx mice in-
jected with clone G13 are not signifi-
cantly different from those in mdx/mdx 
mice injected with HMDSCs treated 
with anti–L-selectin. (b) Expression of
L-selectin ligands on endothelium from 
dystrophic muscle by using intravital
microscopy. Fluorescently labeled anti–
E-selectin, –P-selectin, and –MAdCAM-1 
antibodies were injected in mdx mice, 
and positivity was determined on the 
vascular endothelium of the dystrophic 
muscles. Dystrophic muscles from
2-mo-old mdx/mdx mice expressed 
MAdCAM-1 at venular sites, but not
E- and P-selectin, while aging dystrophic 
vessels did not express L-selectin ligands 
on their surface.
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injected mice. Lungs, liver, brain, and kidneys contained only
a few labeled cells (unpublished data), which corresponded
with the low radioactivity detected in these tissues (Table II;
Fig. 4 i). Tissues from mice not injected with HMDSCs
scored negatively (Fig. 4, i and j).
Vascular endothelium from mdx/mdx muscle 
expresses MAdCAM-1
To further support our results on HMDSCs, we performed
an in vivo study aimed at identifying potential L-selectin
ligands on endothelium from dystrophic muscle. To deter-
mine whether E- and P-selectin and MAdCAM-1 are ex-
pressed on vascular endothelium from mdx striate muscle, we
injected Alexa®488–labeled mAb anti–E-selectin, –P-selectin,
or –MAdCAM-1. 20 min after mAb administration, anti–
E-selectin, –P-selectin, or –MAdCAM-1 antibody accumula-
tion was studied with videomicroscopy (Fig. 5). As shown in
Fig. 5, no positivity for anti-selectin mAbs was detected in
2-mo-old mdx mice. In contrast, positivity for anti–MAd-
CAM-1 antibody was detected on striate muscle venules of
2-mo-old animals, supporting the data that we obtained with
anti–L-selectin blocking antibody. Interestingly, when we
studied the expression of vascular adhesion molecules in older
mdx mice (12 mo old) no positivity was detected for all the Al-
exa®488–labeled antibodies. However, positivity for the anti–
MAdCAM-1 antibody was detected in high endothelial
venules from only young mdx/mdx mice, suggesting that MAd-
CAM-1 may be selectively down-regulated during aging on
the vascular endothelium of dystrophic muscle. An isotype-
matched control antibody revealed no positivity in striated
muscles from young and old mdx mice (unpublished data).
Expression of LacZ and dystrophin in mdx mice 
injected with HMDSCs
We then investigated the in vivo ability of HMDSCs to dif-
ferentiate into the myogenic lineage after i.v. injection. Tis-
sues, shown by radioactivity studies to contain donor cells,
were evaluated for the expression of LacZ and dystrophin
transcripts 3 mo after HMDSC clone G13 engraftment.
The expression of LacZ and dystrophin was investigated by
histochemical staining of cryostat sections of muscles, brain,
liver, lungs, kidneys, and bones of the same host mice.
-Gal–positive nuclei were detected only in striated muscles
of the mdx mice. We observed that 2% of fibers of a cross
section of the pectoralis muscle were not only dystrophin
positive but also contained -gal–positive nuclei (Fig. 4 e).
In the other muscles, the percentage of dystrophin-positive
muscle fibers with -gal nuclei was much lower (0.5–
1.0% of total fibers in a given cross section) (Fig. 4 g). The
dystrophin antibody did not cross-react with autosomal dys-
trophin-related proteins, such as utrophin. Control mdx
muscles contained rare revertant fibers that were dystrophin
positive (Hoffman et al., 1990) but -gal negative.
Discussion
Previous studies have demonstrated the capacity of stem
cells to engraft and participate in muscle repair after a sys-
temic delivery, but they have not identified the mechanism
responsible for the muscle homing of these stem cells
(Goodell et al., 1996, 1997; Ferrari et al., 1998). The factors
that induce stem cells to migrate may be tissue specific or ge-
neric to injury. In the case where we want to verify whether
stem cells migrate after injury, a damage to the muscle with
a needle can induce an inflammatory reaction and muscle
homing. Intramuscular injection of MDSCs into mdx/mdx
mice resulted in a rapid mobilization and incorporation of
donor cells into several distant muscles and bone marrow. As
dystrophic mdx mice have frequent muscle fiber damage due
to the absence of dystrophin (Hoffman et al., 1987), our re-
sults in mdx mice support the notion that injury provides a
sufficient muscle homing.
Using the intravital microscopy method, we identified a
subpopulation of Sca-1/CD34 MDSCs that are responsi-
ble for the migration to the mesodermal derivatives (muscle
and bone marrow) after their i.m. transplantation sharing
the same properties and phenotype (Sca-1, CD34, and
lineage marker negative) as the so-called SP. We found that
only 30% of the Sca-1/CD34 MDSCs express the
L-selectin adhesion molecule. Clones of these stem cells re-
sulted in a corresponding enrichment in the transplantable
muscle content of this subset. Moreover, these clones ex-
pressed a high level of MMP-2 and MMP-9, two matrix-
degrading metalloproteinases that play an important role in
Table II. Tissue distribution of [3H]glycerol-labeled HMDSCs after the injection of mdx mice
HMDSCs HMDSCs  anti–L-selectin HMDSCs  F(ab) anti–L-selectin Cell lysates
%/g %/g %/g %/g
Soleus muscle 31 
 0.05 8.72 
 0.09 9.02 
 0.1 1.24 
 0.01
Pectoralis muscle 22.45 
 0.10a 3.2 
 0.37 3.3 
 0.41 0.32 
 0.04
Tibialis anterior muscle 12.15 
 0.01 3.5 
 0.53 3.55 
 0.65 0.7 
 0.02
Triceps brachialis muscle 5.31 
 0.02a 1.2 
 0.01 1.23 
 0.07 1.18 
 0.01
Diaphragm 33.05 
 0.07a 6.18 
 0.02 6.18 
 0.06 0.12 
 0.21
Liver 2.34 
 2.10 1.2 
 0.07 1.25 
 0.09 6.23 
 0.01
Kidney 4.74 
 0.37 1.8 
 0.02 1.9 
 0.04 1.44 
 0.05
Lung 1.5 
 0.01 1.3 
 0.15 1.1 
 0.25 3.6 
 0.02
Bone marrow 1.8 
 0.55 0.9 
 0.32 0.7 
 0.56 0.54 
 0.1
Brain 0.28 
 0.2 0.2 
 0.1 0.21 
 0.15 1.18 
 0.2
Radioactivity distribution in muscles and visceral organs of 2-mo-old mdx/mdx mice after the injection of [3H]glycerol-labeled HMDSCs with or without
anti–L-selectin or the injection of cell lysates. Results are expressed as percentage of injected activity per gram of tissue (
 SD) 2 h after i.v. injection.
aP  0.01 vs. HMDSCs  anti–L-selectin.
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tissue remodeling and in processes involved in cell migration
(Birkedal-Hansen et al., 1993).
Sca-1/CD34/L-selectin MDSCs (HMDSCs) did not
“home” specifically to the muscle tissues. We found, how-
ever, a few of them in spleen, liver, lung, and brain after i.v.
injection. Thus muscle homing was probably related to a
high expression of the L-selectin ligands on the vessels of in-
flamed muscles, as is the case for dystrophic muscles (Beren-
son et al., 1988). Importantly, we found that endothelium
from dystrophic muscle expresses MAdCAM-1, but not E-
and P-selectin. MAdCAM-1 is a ligand for L-selectin that
expressed selectively at venular sites of lymphocyte extravasa-
tion into mucosal lymphoid tissues and lamina propria,
where it directs local lymphocyte trafficking (Berg et al.,
1993; Briskin et al., 1993). It has been previously shown
that MAdCAM-1 is also expressed on chronically inflamed
endothelium from nonlymphoid organs and mediates the
recruitment of leukocytes into sites of inflammation (Yang
et al., 1997; Connor et al., 1999; Hillan et al., 1999; Souza
et al., 1999; Kanwar et al., 2000). Our results represent the
first demonstration that vascular endothelium from dystro-
phic muscle is able to express MAdCAM-1. Interestingly, we
show that only blood vessels from young mdx mice express
MAdCAM-1, whereas older mice down-regulate the mu-
cosal addressin from their surface.
Although antibody against L-selectin reduced muscle
homing of HMDSCs, some attachment of HMDSCs to the
muscle tissues was still observed after this blockade. The re-
maining homing capacity could be attributed either to an in-
complete blocking of all L-selectin molecules on the HMDSCs
or to the rapid expression of new L-selectin sites on these
cells. However, an alternative hypothesis is that other cell
adhesion molecules may be involved in the in vivo muscle
homing of HMDSCs. Collectively, these findings showed
that muscle homing may result from a mixture of pathways
including tissue-specific interactions between L-selectin ad-
hesion molecules of stem cells and ligands present on the en-
dothelium layer of blood vessels after local damage.
The absence of L-selectin antigen after the commitment
of HMDSCs indicates a possible functional role in the
maintenance of a “primitive” state of multipotent stem cells
that coincides with their homing properties. In this regard, it
is interesting that L-selectin is also expressed in the earliest
hematopoietic stem/progenitor cells (HSPCs) and in inter-
mediate stages of leukocyte development, and all erythroid
and megakaryocytic lineage cells are devoid of L-selectin ex-
pression (Kansas et al., 1990; Terstappen et al., 1992; Sack-
stein, 1997). Moreover, several studies have indicated L-selec-
tin as a “bone marrow homing molecule” (Mazo et al., 1998;
Greenberg et al., 2000), suggesting a role for L-selectin ad-
hesive interactions with its ligand in the creation and/or per-
petuation of HSPC microenvironmental niches after he-
matopoietic stem cell transplantation (Dercksen et al., 1995;
Watanabe et al., 1998; Koenig et al., 1999). In agreement
with these data, we observed a reconstitution of the hemato-
poietic compartment of lethally irradiated mdx/mdx recipi-
ents after injection of HMDSCs.
The Sca-1/CD34/L-selectin cells differentiate well in
vitro in myogenic lineage and can rescue the dystrophic
phenotype after their i.v. injection into mdx/mdx mice.
However, the muscle dystrophin restoration was below the
levels needed to provide clinical benefits in DMD and not
in correspondence with the high attachment to muscle
blood vessels observed 2 h after i.v. injection of HMDSCs.
It is possible that these cells are in competition with the res-
ident stem cells for muscle fiber repair. In the case of bone
marrow transplantation, the damage is usually whole body
irradiation or other myeloablative agents (Hendrikx et al.,
1996). Both approaches probably kill bone marrow stem
cells and result in a free stem cell niche where the injected
bone marrow stem cells can home (Jackson et al., 1999;
Wright et al., 2002) and have no competition. The pres-
ence of only a few HMDSCs in the bone marrow of mdx/
mdx mice not irradiated and the total reconstitution ob-
tained after irradiation agree with this interpretation. Addi-
tionally, muscle incorporation of the HMDSCs initially at-
tached to the muscle blood vessels may prevalently generate
satellite cells (as indicated by in vitro differentiation experi-
ments), which did not fuse with existing muscle fibers in
the time course of this experiment.
The HMDSCs attached initially to the muscle blood ves-
sels may remain as a multipotent circulating pool of cells
(Delassus and Cumano, 1996; Shi et al., 1998) and eventu-
ally migrate to other tissues during their life span. The pro-
gressive muscle degeneration and vessel wall calcification
present in the dystrophic muscles may significantly reduce
the migration of HMDSCs in the damaged muscle tissue
(unpublished data). In the future, stem cell transplantation
could be optimized by performing them during the initial
stage of DMD disease to provide levels of muscle engraft-
ment that would be clinically useful. Our results show an
important observation that will help to start the investiga-
tion of the mechanism of muscle homing, and this may
eventually aid in improving the efficacy of the systemic de-
livery of stem cells to repair dystrophic muscles.
Materials and methods
Transgenic mice
This work was authorized and supervised by the CHUQ Animal Care
Committee and was conducted according to the guidelines set by the Ca-
nadian Council of Animal Care. Muscle-derived cells were established
from the ROSA-26 animals (Jackson ImmunoResearch Laboratories) and
the Des-LacZ strain (gift from D. Paulin, Paris University, Paris, France)
where the -gal gene was expressed only in skeletal muscle (Li et al.,
1997).
Isolation of MDSCs
Muscle-derived cells were isolated using a previously described protocol
(Rando and Blau, 1994; Torrente et al., 2001) and preplated in noncoated
flasks with Ham’s F10 supplemented with 20 g/ml pancreatic insulin, 50
ng/ml stem cell factor, 15% FBS, and 1% penicillin/streptomycin. All the
culture medium supplies were purchased from GIBCO BRL. Sca-1 cells
were purified by positive selection by using the Sca-1 multisort kit (Mil-
tenyi Biotec). After the isolation of Sca-1 cells, multisort microbeads were
removed using the MACS® multisort release reagent, and the Sca-1 cells
were incubated with a biotinated, conjugated CD34 antibody (1/50) and
resuspended with an antibiotin conjugated with paramagnetic microbeads
(Miltenyi Biotec). After selection, aliquots of the Sca-1/CD34, Sca-1/
CD34, Sca-1/CD34 cell fractions were analyzed to assess purity. For
two-color flow cytometry, FITC–anti-CD34 (BD Biosciences) and phyco-
erythrin-conjugated anti–Sca-1 Mab (Miltenyi Biotec) were used as previ-
ously described (Forni, 1979; Gehling et al., 1997; Lange et al., 1999; Na-
kamura et al., 1999). Flow cytometric analysis was performed on a
FACScan® flow cytometer using Cell Quest software (Becton Dickinson)
with 10,000 events recorded for each sample.
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Clonogenic and differentiation potential 
of Sca-1/CD34 MDSCs
For clonal analysis, the Sca-1/CD34 isolated cells were resuspended in
uncoated wells of 96-well plates (1 cell/well) and cultured with the prolif-
erating medium as above. Only the wells containing a single cell were
used. The ability of Sca-1/CD34 MDSCs to undergo differentiation into
myogenic lineage was tested with Ham’s F10 supplemented with 5% FBS,
and after 14 d of culture, differentiated myoblasts were detected by immu-
nostaining with antibodies against desmin (1:100; Sigma-Aldrich), MyHC
(1:200; Ylem), and m-cadherin (1:50; Santa Cruz Biotechnology, Inc.). For
Western blot analyses, 100 g of extracted proteins was separated on 6%
polyacrylamide gels and electrotransferred onto nitrocellulose membranes
(Bio-Rad Laboratories) and incubated with monoclonal antibodies directed
against either dystrophin, utrophin, or m-cadherin and revealed using a
commercially available chemiluminescence kit (Ultra ECL; Pierce Chemi-
cal Co.). Metalloproteinase activity was assessed using 10% gelatin zymo-
gram gels, as described previously (El Fahime et al., 2000).
Intramuscular transplantation of MDSCs into mdx
5  105 MDSCs prepared from newborn male F1 Balb/c(H2d)-
C57BL10J(H2b) mice and Sca1/CD34 MDSCs from newborn male Des-
LacZ mice (H2b) were injected into the right TA of three groups each of
five female 2-mo-old C57BL/10ScSn mdx/mdx (H2b) mice. Mice were
anesthetized with an i.p. injection of physiologic saline (10 ml/kg) contain-
ing ketamine (5 mg/ml) and xylazine (1 mg/ml). Detection of chromosome
Y was performed as previously described (Caron et al., 1999). To verify tol-
erance induction after transplantation, we examined Balb/c skin grafts
placed on C57BL/10ScSn mdx/mdx mice. Skin from the tails of Balb/c do-
nors was engrafted to the backs of three C57BL/10ScSn mdx/mdx recipi-
ents (Rosenberg, 1991). The grafts were examined daily for evidence of
edema, hair growth, and rejection.
Intravital microscopy
Muscle homing and vascular adhesion properties were also verified into
the pectoral muscle of three groups of mdx/mdx mice (n 	 15) injected
into the TA muscles with 5  105 of each subpopulation of MDSCs (i.e.,
Sca-1/CD34, Sca-1CD34, and Sca-1CD34) as previously de-
scribed (Torrente et al., 2001). An intravital microscope (Olympus
BX50WI) equipped with water immersion objectives (Olympus Achroplan;
focal distance 3.3 mm, NA 0.5) was used for these experiments. The
MDSCs were fluorescently labeled with 2’,7’-bis-(carboxyethyl)-5(and-6)
carboxy-fluorescein (BCECF; Molecular Probes). All scenes were recorded
on videotape using a silicon-intensified target video camera (VE 1000-SIT;
Dage MTI), a time and frame counter (ELCA), and a high picture quality
SVHS Panasonic VCR.
Intravenous transplantation of MDSCs into lethally 
irradiated mdx mice
The Sca-1CD34 MDSCs and bone marrow cells were obtained from
Balb/c newborn mice (H-2d haplotype) and injected intravenously into le-
thally irradiated (950 cGy) C57BL/10ScSn mdx/mdx (H-2b haplotype). Ani-
mals were then followed for 8 wk. No changes in general health status were
noted in recipient mice. 20 C57BL/10ScSn mdx/mdx mice received 5  107
bone marrow–derived cells. 20 C57BL/10ScSn mdx/mdx mice received both
the Sca-1CD34 MDSCs (50  104) and bone marrow–derived cells (5 
106). Two groups served as controls. Five C57BL/10ScSn mdx/mdx mice re-
ceived pooled bone marrow cells from Balb/c mice after irradiation (control
1). Four C57BL/10ScSn mdx/mdx mice were irradiated and did not receive
cell transplantation to determine whether the irradiation dose chosen was le-
thal (control 2). All four of these mice died within 2 wk. For transplantation
into secondary recipients, bone marrow was harvested from a rescued mdx/
mdx mouse, and 8  105 mononucleated cells were injected into each of
five mdx/mdx recipients, prepared as described above.
In vivo histochemistry and immunocytochemistry
For histochemistry on tissue sections, samples were frozen in liquid nitro-
gen–cooled isopentane and cryostat sectioned. Slides were examined by
light microscopy for -gal–positive myofibers (Li et al., 1993). Detection of
dystrophin was performed with a polyclonal antibody against the COOH
60-kD Dys fragment (gift of J.S. Chamberlain, University of Michigan, Ann
Arbor, MI). Antibodies were visualized using an HRP-coupled secondary
antibody (Bio-Rad Laboratories). The Lac-Z, dystrophin double-positive
myofibers were counterstained with hematoxylin and eosin. A fluores-
cence microscope (Leica DMIR2) equipped with Leica Qfluoro software
was used for these experiments.
Characterization of muscle homing by [3H]glycerol labeling 
and autoradiography
5  105 HMDSCs were incubated overnight at 37C in RPMI supple-
mented with 10 Ci/ml [3H]glycerol (Dupont), as previously described
(Constantin et al., 1997), and injected intravenously into mdx/mdx mice.
Animals were killed 2 h later, muscle, lung, kidney, liver, and blood tis-
sues were collected, and radioactive content was measured in a -counter
(LS1801; Beckman Coulter). We compared the distribution of radioactivity
of five 2-mo-old mdx/mdx mice injected i.v. with 10  105 HMDSCs with
five dystrophic animals injected with HMDSCs pretreated for 15 min at
room temperature with 100 g/l anti–L-selectin MEL-14 (gift from E.C.
Butcher, Stanford University, Stanford, CA). To assure a longer blocking of
the L-selectin on HMDSCs, L-selectin pretreatment was accompanied by
i.v. injection of anti–L-selectin (400 g/ml of antibody diluted in 500 l of
sterile HBSS). To exclude the potential effects of the complement, the
F(ab’)2 fragment of anti–L-selectin was generated using the immunoPure
F(ab’)2 preparation kit (Pierce Chemical Co.) as previously described (La-
moyi, 1986). In this experiment, five mdx/mdx animals were injected with
HMDSCs pretreated for 15 min at room temperature with 100 g/l of
F(ab’)2 anti–L-selectin. For histologic localization of radiolabeled cells, 8-m
frozen sections of muscle tissues were placed on Histostick-coated slides
(Accurate Chemicals), fixed with methanol, and washed with PBS. The
slides then were dipped in Kodak NTB 2 emulsion (Eastman Kodak Co.)
and exposed for 6 wk at 4C. The slides were developed and fixed using
EDF/EDP Photochemicals (Eastman Kodak Co.) according to the process-
ing protocol from the manufacturer.
In vivo staining of endothelial adhesion molecules
MAbs anti–E-selectin, –P-selectin, and –MAdCAM-1 and an isotype-
matched control antibody (anti–human Ras) were labeled using the Alexa
Fluor®488 labeling kit (Molecular Probes). 50 g fluorescent mAb was in-
jected intravenously. 20 min later, the animal was anesthetized and per-
fused through the left ventricle with cold PBS (Piccio et al., 2002). Striate
muscle vessels were visualized using the intravital microscopy setting as
described for intravital microscopy experiments. Anti–L-selectin mAb
Mel-14 was from American Type Culture Collection. Anti–E-selectin and
–P-selectin antibodies (RME-1 and RMP-1) were obtained as previously de-
scribed (Walter et al., 1997a,b). Anti–MAdCAM-1 was provided by E.C.
Butcher. Green CMFDA (5-chloromethylfluorescein diacetate) for the la-
beling of HMDSCs for intravital microscopy was prepared as a stock solu-
tion in DMSO and kept at 20C until the moment of use.
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